This discrepancy may be due in part to decreased secretion of chemokine CCL4 by melanoma cells arising from active β-catenin signaling, resulting in hampered CD103+ DC tumor infiltration and impeded CD103+ DC chemotaxis (106). The gene discussed is ITGAE; the disease is neoplasm.